{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:47:59Z","timestamp":1782204479278,"version":"3.54.5"},"reference-count":27,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Angiographic no-reflow (NRF) after percutaneous coronary intervention (PCI) reflects impaired microvascular reperfusion despite successful treatment of the epicardial culprit lesion. Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in endothelial signaling, platelet biology, inflammation, and angiogenesis. Its relationship with NRF in non-ST-segment elevation myocardial infarction (NSTEMI) remains insufficiently characterized. Materials and Methods: This single-center prospective observational cohort study included 700 consecutive NSTEMI patients undergoing culprit-lesion PCI. Admission serum total BDNF was measured before PCI using a standardized enzyme-linked immunosorbent assay protocol. Angiographic NRF was defined as final thrombolysis in myocardial infarction (TIMI) flow &lt;3 and\/or TIMI 3 flow with myocardial blush grade (MBG) 0\u20131 in the absence of residual stenosis, dissection, severe spasm, or other mechanical obstruction. Four sequential logistic regression models were used to evaluate the stability of the association between BDNF and NRF: Model 1 adjusted for clinical variables; Model 2 further adjusted for laboratory and inflammatory variables; Model 3 further adjusted for cardiac injury and functional variables; and Model 4 further adjusted for angiographic and procedural variables. Discrimination, calibration, reclassification, decision-curve analysis, and internal validation were assessed. Results: NRF occurred in 114 of 700 patients (16.3%). Serum total BDNF was higher in the NRF group than in the reflow group [555 (465\u2013688) vs. 386 (292\u2013496) pg\/mL, p &lt; 0.001]. BDNF remained independently associated with NRF across sequential models: Model 1 OR 1.67 per 100 pg\/mL (95% CI 1.43\u20131.96), Model 2 OR 1.49 (95% CI 1.24\u20131.79), Model 3 OR 1.41 (95% CI 1.16\u20131.72), and Model 4 OR 1.31 (95% CI 1.07\u20131.60). The BDNF-only AUC was 0.787, while the final BDNF-enriched Model 4 reached an AUC of 0.866. The optimism-corrected bootstrap AUC was 0.852 and the 10-fold cross-validated AUC was 0.845. Conclusions: Higher admission serum total BDNF was independently associated with angiographic NRF in NSTEMI patients undergoing PCI and improved risk discrimination when added to clinical, biochemical, cardiac, and angiographic predictors. These findings suggest that serum total BDNF may reflect a context-dependent biomarker signal related to acute thrombo-inflammatory, platelet-associated, and microvascular injury pathways; however, the observed incremental value was modest and requires external validation.<\/jats:p>","DOI":"10.3390\/medicina62071211","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:13:37Z","timestamp":1782195217000},"page":"1211","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Admission Serum Total Brain-Derived Neurotrophic Factor and Angiographic No-Reflow in Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-2033","authenticated-orcid":false,"given":"Alp","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Ahi Evran University, 40100\u00a0Kirsehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-1564","authenticated-orcid":false,"given":"Mustafa","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Necmettin Erbakan University, 42090 Konya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8046-3185","authenticated-orcid":false,"given":"M\u00fczeyyen Gizem","family":"Parmak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Ahi Evran University, 40100\u00a0Kirsehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-0064","authenticated-orcid":false,"given":"Muhammet Salih","family":"Ate\u015f","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Ahi Evran University, 40100\u00a0Kirsehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8170-5912","authenticated-orcid":false,"given":"Erdo\u011fan","family":"S\u00f6kmen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Ahi Evran University, 40100\u00a0Kirsehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0092-652X","authenticated-orcid":false,"given":"Kenan","family":"G\u00fc\u00e7l\u00fc","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Kayseri State Hospital, 38030 Kayseri, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","first-page":"950","article-title":"Coronary no-reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory","volume":"72","author":"Rezkalla","year":"2008","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","article-title":"Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention","volume":"117","author":"Jaffe","year":"2008","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/hrt.2003.020800","article-title":"Optimal therapeutic strategies in the setting of post-infarct no-reflow: The need for a pathogenetic classification","volume":"90","author":"Galiuto","year":"2004","journal-title":"Heart"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MCA.0000000000000781","article-title":"The CHA2DS2-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction","volume":"31","author":"Barman","year":"2020","journal-title":"Coron. Artery Dis."},{"key":"ref_6","first-page":"649","article-title":"Association of epicardial fat tissue thickness with thrombus burden and no-reflow in patients with non-ST-segment elevation myocardial infarction","volume":"21","author":"Kurtul","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yjmcc.2017.07.007","article-title":"BDNF\u2014A key player in cardiovascular system","volume":"110","author":"Machalinski","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tcm.2007.03.002","article-title":"Brain-derived neurotrophic factor: A newly described mediator of angiogenesis","volume":"17","author":"Kermani","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1139\/bcb-2013-0005","article-title":"BDNF protects human vascular endothelial cells from TNF-alpha-induced apoptosis","volume":"91","author":"Takeda","year":"2013","journal-title":"Biochem. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vph.2018.02.005","article-title":"Activation of endothelial TrkB receptors induces relaxation of resistance arteries","volume":"106","author":"Totoson","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","article-title":"Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?","volume":"6","year":"2016","journal-title":"World J. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Le Blanc, J., Fleury, S., Boukhatem, I., Belanger, J.C., Welman, M., and Lordkipanidze, M. (2020). Platelets selectively regulate the release of BDNF, but not that of its precursor protein, proBDNF. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.575607"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14990","DOI":"10.1038\/s41598-025-98213-7","article-title":"Relationship between serum mature brain-derived neurotrophic factor level and coronary slow flow phenomenon: A cross-sectional study","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.trsl.2020.11.006","article-title":"Brain-derived neurotrophic factor in patients with acute coronary syndrome","volume":"231","author":"Montone","year":"2021","journal-title":"Transl. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1536\/ihj.24-748","article-title":"BDNF regulation of myocardial infarction","volume":"66","author":"Zhang","year":"2025","journal-title":"Int. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: A quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","article-title":"Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade","volume":"97","author":"Liem","year":"1998","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00007.2008","article-title":"Cardiovascular actions of neurotrophins","volume":"89","author":"Caporali","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/1358863X15598390","article-title":"Vascular function and brain-derived neurotrophic factor: The functional capacity factor","volume":"20","author":"Alomari","year":"2015","journal-title":"Vasc. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/life11010070","article-title":"The emerging role of BDNF\/TrkB signaling in cardiovascular diseases","volume":"11","author":"Hang","year":"2021","journal-title":"Life"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jin, H., Chen, Y., Wang, B., Zhu, Y., Chen, L., Han, X., Ma, G., and Liu, N. (2018). Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0762-z"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2007.03.009","article-title":"Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data","volume":"73","author":"Trajkovska","year":"2007","journal-title":"Brain Res. Bull."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1211\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:00:01Z","timestamp":1782201601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071211"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071211","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}